FDA approves chloroquine for emergency COVID-19 trials Recommends clinical trials to test drug’s effectiveness • Approves it as emergency treatment, despite lack of clinical data • Israel’s Magen David Adom to treat coronavirus patients with “passive vaccine.” April 2, 2020
Teva to send millions of tablets to US hospitals for possible treatment of virus The company said 6 million doses will be delivered by March 31 and more than 10 million in a month. March 27, 2020
Teva reaches $85 million settlement with Oklahoma in opioid abuse suit Like other opioid producers, Teva is facing lawsuits in the United States, having been accused of worsening the opioid crisis. June 25, 2019
Teva projects generic version of EpiPen to consist of a quarter of US market After a several-year delay, Teva received U.S. approval for its EpiPen in August 2018, but Schultz said more “validations” were mandated by the U.S. Food & Drug Administration, which it has completed. Feb. 20, 2019
Buffett’s Berkshire Hathaway doubles shares of Teva It now owns a 3.45 percent stake in the Israeli generic pharmaceutical company. May 16, 2018
